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Abstract
Background: Although integrins have been implicated in the progression of breast cancer, the exact mechanism
whereby they exert this regulation is clearly not understood. To understand the role of integrins in breast cancer,
we examined the expression levels of several integrins in mouse breast cancer cell lines by flow cytometry and the
data were validated by Western and RT-PCR analysis. The importance of integrins in cell migration and cell invasion
was examined by in vitro assays. Further the effect of integrins on metastasis was investigated by in vivo
experimental metastasis assays using mouse models.
Results: Integrin a5 subunit is highly expressed in the nonmetastatic cell line 67NR and is significantly low in the
highly invasive cell line 4T1. In contrast, expression levels of integrin a6 subunit are high in 4T1 cells and low in
67NR cells. In vitro data indicated that overexpression of a5 subunit and knockdown of a6 integrin subunit
inhibited cell proliferation, migration, and invasion. Our in vivo findings indicated that overexpression of integrin a5
subunit and knockdown of a6 subunit decreased the pulmonary metastasis property of 4T1 cells. Our data also
indicated that overexpression of alpha 5 integrin subunit and suppression of alpha6 integrin subunit inhibited cells
entering into S phase by up-regulating p27, which results in downregulation of cyclinE/CDK2 complexes, This
suggests that these integrins regulate cell growth through their effects on cell-cycle-regulated proteins. We also
found that modulation of these integrins upregulates E2F, which may induce the expression of chk1 to regulate
cdc25A/cyclin E/CDK2/Rb in a feedback loop mechanism.
Conclusion: This study indicates that Integrin a5 subunit functions as a potential metastasis suppressor, while a6
subunit functions as a metastasis promoter. The modulation of integrins reduces cdc25 A, another possible
mechanism for downregulation of CDK2. Taken together we demonstrate a link between integrins and the chk1-
cdc25-cyclin E/CDK2-Rb pathway.
Background
Tumor metastasis is a highly complex multistep process
involving unregulated cell growth, cell-cell and cell-
matrix interactions, cell adhesion, angiogenesis, and
growth of new cancer colonies [1]. During these steps,
the expression level of some genes is altered. Thus,
these genes, once identified, can serve as bio-markers of
metastatic diagnosis and prognosis. Over the past
decade, a variety of genes have been identified that are
altered in tumor growth and metastasis [2].
Integrins are a family of transmembrane glycoprotein
adhesion receptors that mediate cell-matrix and cell-cell
adhesion. They are the main receptors for sensing the
extracellular environment of the cell [3]. Integrins form
heterodimers of a and b subunits [4]. Eighteen a subu-
nits and eight b subunits can associate to form 24
unique integrin heterodimers. Numerous studies have
shown that in addition to sensing the extracellular
environment, integrins are involved in various intracel-
lular pathways, including cell adhesion, migration, polar-
ity, survival, growth and death [3,5,6], suggesting their
* Correspondence: salaha@lsuhsc.edu
† Contributed equally
1Department of Biochemistry and Molecular Biology, Stanley Scott Cancer
Center, LSU Health Sciences Center, New Orleans, LA 70112, USA
Full list of author information is available at the end of the article
Wang et al. Molecular Cancer 2011, 10:84
http://www.molecular-cancer.com/content/10/1/84
© 2011 Wang et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.important role in cancer [4]. Furthermore, integrins
were shown to be differentially expressed during tumor
growth and progression, making them potential targets
for cancer diagnosis and therapy [3,5,6].
The mechanisms whereby integrins function in tumor
cells are yet to be determined. However, some cancer-
related proteins, such as focal adhesion kinase (FAK) [7]
and Nischarin [8] can bind to and interact with integ-
rins. Therefore, we investigated whether integrins are
differentially expressed in highly metastatic cells com-
pared with non-metastatic cells, and examined the effect
of these differentially expressed integrins on cell prolif-
eration, invasion and the potential of metastasis.
In this study we used mouse breast cancer cell lines
4T1, 4T07, and 67NR because they represent a good
model for the study of breast cancer metastasis. 4T1,
4T07, and 67NR are derived from the same BALB/c
mammary tumor and are highly tumorigenic, but vary in
their metastatic potential. 4T1 widely disseminates,
resulting in secondary tumors in the lung, liver, bone,
and brain; 4T07 spreads to the lung and liver but cannot
establish metastatic nodules; 67NR does not metastasize
[9,10]. Our study shows that integrin a5s u b u n i tf u n c -
tions as a candidate metastasis suppressor, while a6s u b -
unit promotes tumor metastasis in 4T1 cell lines through
the modulation of pathways regulated by the cell cycle.
Materials and methods
Cell lines
Mouse mammary carcinoma cells 4T1, 4T07, and 67NR
were cultured in Dulbecco’s Modified Eagle’sM e d i u m
(DMEM) supplemented with 10% fetal bovine serum
(FBS). Cells were incubated at 37°C with 5% (w/v) CO2
and 95% (w/v) air mixture.
Flow cytometry
One million 4T1, 4T07, and 67NR cells were incubated
with primary antibodies against integrins a4( c l o n eP S /
2), a5 (clone 5H10-27), a6 (clone NKI-GoH3), b1
(clone MB1.2), b2 (clone M18/2), a2b1 (clone BMA2.1),
a5b1 (clone BMA5), and avb6 (clone 10D5) for 30 min
at 4°C in phosphate-buffered saline containing 1% FBS.
Cells were then washed twice with ice-cold PBS and
incubated with FITC-conjugated secondary antibodies
(1:1,250) for 30 min at 4°C. Most antibodies were pur-
chased from Millipore (Madison, WI); the exception was
integrin a5, which was purchased from Abcam (Cam-
bridge, MA). Relative amounts of cell surface integrins
were determined using a FACScan cytometer with Cell-
Quest software (Becton-Dickinson, San Jose, CA).
RT-PCR
Total RNAs from these cell lines were isolated using a
RNeasy kit (Qiagen, Valencia, CA). RNA quality was
determined with the Agilent Bioanalyser 2100 and
RNA Nano 6000 Labchip kit (Agilent Technologies,
Palo Alto, CA). RNA concentrations were determined
with a NanoDrop apparatus (NanoDrop Technolo-
gies). RT-PCR was done to confirm expression of
integrins a5a n da6 by one-step RT-PCR (Qiagen).
Briefly, the 25 μl RT-PCR reaction included 100 ng
total RNA, 5 μl 5 × RT-PCR buffer, 0.4 mM dNTP,
0.6 μM forward and reverse primers, and 1 μle n z y m e
mix. The reactions were incubated in a 96-well plate
at 50°C for 30 min and 95°C for 15 min, followed by
25 cycles of 95°C for 15 sec, 60°C for 30 sec, 72°C for
30 s, and 72°C for 7 min. The primers used in RT-
PCR were:
For integrin a5: forward: 5’-GGACCAAGACGGCTA-
CAATGATGT-3’;
Reverse: 5’-ACCTGGGAAGGTTTAGTGCTCAGT-3’.
For Integrin a6: forward: 5’-AAAGAGACAT-
GAAGTCCGCGCATC-3’;
Reverse: 5’-AACAATGTCTTGCCACCCATCTGC-3’.
For CHK1: forward: 5’-TGGACAAACTGGTT-
CAGGGCAT-3’;
Reverse: 5’-TGCTCACAACATCGCTGAGCTT-3’.
For E2F1: forward: 5’-ACCCAGGGAAAGGTGT-
GAAA-3’;
Reverse: 5’-AAAGCAGTTGCAGCTGTGTGGT-3’.
For GAPDH forward: 5’-AACATCATCCCTGCATC-
CACTGGT-3’;
Reverse: 5’-TGTTGAAGTCGCAGGAGACAACCT-3’.
The RT-PCR products were determined by electro-
phoresis on 2% agarose gel stained with ethidium
bromide.
Western blotting
Cells were washed twice using ice cold PBS. Cell lysates
were prepared using RIPA buffer (50 mM Tris, pH 7.5;
1% NP-40; 0.1% sodium deoxycholate; 150 mM NaCl;
50 mM NaF; and 1 mM sodium pyrophosphate). Lysates
were centrifuged at 20,000 × g for 20 min at 4°C. Small
aliquots (10 μl) of the supernatant were used for deter-
mining protein concentrations by a bicinchonic acid
assay (Pierce; Rockford, IL). Proteins (20-50 μg) were
separated by SDS-polyacrylamide electrophoresis on 6%
or 12% polyacrylamide gels and transferred to PVDF
membranes (GE Healthcare Biosciences, Piscataway, NJ).
Blots were blocked in 5% milk and 0.1% Tris-buffered
saline-Tween 20 for 1 hr at room temperature. Blots
were incubated with antibodies against integrin a5 sub-
unit (1:1000; Millipore, Madison, WI) and integrin a6
subunit (1:500; Santa Cruz Biotechnology, Santa Cruz,
CA). Membranes were washed 4X for 5 min each time
using PBS Tween 20 and incubated with anti-mouse or
anti-rabbit horseradish-peroxidase-conjugated secondary
antibodies (1:2,000; Santa Cruz Biotechnology).
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noblotting detection system (GE Healthcare
Biosciences).
Construction of stable cell lines overexpressing integrin
a5 and knockdown integrin a6
We used the expression plasmid pcDNA 3.1/ITGA5,
which contains the full length of integrin a5 subunit, to
transfect 4T1 cells by the Lipofectamine 2000 method
(Life Technologies, Rockville, MD). The transfected cells
were subjected to 1 mg/mL G418 selection. Several
G418-resistant clones were tested for integrin a5 subu-
nit overexpression. The mixture of positive clones was
used for further studies.
Two integrin a6 subunit oligos were designed by
selecting appropriate sequences from the mouse integrin
a6 gene (NM_008397) and named shRNA-1 and
shRNA-control. The sequences of the two shRNAs were
as follows:
shRNA-: 5’-GATCCCCCCTTGTACACGGATTGAA
TTTCAAGAGAATT CAATCCGTGTACAAGGTT
TTTA-3’;
shRNA-control: 5’-GATCCCCGGACAACGTGAT
CCGGAA ATTCAAGAGATTTCCGGATCACGTTGT
CCTTTTTA-3’
The double strands for shRNA-1 and shRNA-control
oligos were cloned into GeneScript shRNA expression
vector, pRNAT-H1.1/Neo (Cat# SD1213-Genescript,
NJ), using the BamH1 and HindIII restriction enzyme
sites. The oligo insertion was confirmed by sequencing.
After plasmid transfection, cells were cultured in G-418
(500 ug/ml) and several clones were isolated. The indivi-
dual clones were characterized and positive clones were
selected RT-PCR and Western blot analysis.
Cell proliferation analysis
To examine cell proliferation, we used MTT calorimetry
assays (Millipore, Madison,W I ) .C e l l sw e r eh a r v e s t e d ,
resuspended, and plated in 96-well plates at 1 × 10
3
cells per well in 100 μL of cell culture medium and
maintained at 37°C in a humidified incubator containing
5% CO2. After every 24 h, 10 μLo ft h eM T Ts o l u t i o n
was added to the triplicate wells and incubated at 37°C
for another 4 h. Also, 100 μL of color development solu-
tion was added and incubated for 10 min to dissolve the
crystal completely. Then we measured the absorbance at
572 nm, using a plate reader to calculate the numbers
of vital cells in each well.
Cell migration and cell invasion analysis
In vitro cell migration and invasion assays were done
as per our previously reported protocols [8,11]. Briefly,
4 T 1( c o n t r o l ) ,4 T 1 - G F P ,4 T 1 - a5, or 4T1-a6.shRNA1
cells (1 × 10
5) were suspended in 100 μLo fs e r u m - f r e e
DMEM and added on top of the transwell (8.0 μM
pore size; Corning, NY) chambers (for migration) or
on top of the Matrigel-coated transwells (30 μLo f
serum-free DMEM-diluted matrigel; BD Biosciences,
San Jose, CA) (for invasion) in triplicate. The DMEM
plus 10% FBS culture medium was added to the lower
chamber to serve as a chemoattractant. After 6 h
(migration) or 24 h (invasion) of incubation at 37°C,
the upper surfaces of the filters were carefully wiped
with a cotton-tipped applicator. The filters were fixed
with 4% paraforrmaldehyde in PBS and stained with
0.1% crystal violet solution. In some cases, cell migra-
tion was performed either on fibronectin or laminin
matrices. Cells that had migrated or invaded (Matrigel)
through the transwell filter pores toward the lower
surface of the filters were counted in five different
fields under a light microscope.
Cell cycle analysis
4T1 (control), 4T1-GFP, 4T1-a5, and 4T1-a6-shRNA1
cells were stained for DNA content as per our pre-
viously described protocols [12]. Briefly, cells were tryp-
sinized and resuspended in 200 μL ice-cold PBS, after
which 4 ml of cold 70% ethanol was added to the mix-
ture. Cells were incubated at 4°C for 45 min. Subse-
quently, cells were centrifuged at 1,500 g for 10 min at
4°C and resuspended in PI master mix, consisting of
propidium iodide 40 ug/ml and RNAse 100 ug/ml
(Sigma) at 37°C for 30 min. Cells were then analyzed
using an LSR II cytometer. PI staining intensity was
determined by Modfit software.
Cell-cycle genes PCR Array
Total RNA was extracted and measured as previously
described [12]. RNA was used to probe GE arrays con-
taining cell-cycle-related genes as per the manufacturer’s
recommendations (SuperArray Bioscience). Raw data
were normalized by GEarray Analyzer software. Data
were normalized with control groups (4T1-a5 data nor-
malized with 4T1-GFP and 4T1 a6-1 data normalized
with 4T1 control shRNA).
In-vivo metastasis assay
Twenty five nude mice (NCI) were maintained as per
the guidelines of the AALAC and the IACUC LSU
Health Sciences Center at New Orleans. These mice
were randomly allocated to five groups for tail vein
injections of 4T1 control, 4T1-GFP, 4T1-a5, or 4T1-
a6-shRNA1 cells. Cells were grown to 80% con-
fluency and harvested in cold PBS. 1 × 10
6 cells in 0.1
ml PBS were injected into nude mice via lateral tail
vein injection. These mice were then used in the fol-
lowing experiments, each of which was repeated three
times.
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After 4 weeks, mice were euthanized. Their lungs were
removed and perfused with buffered formalin through
the cannulated trachea. Paraffin wax sections were
stained with hematoxylin and eosin (H&E) and Ki67
using standard procedures, and the sections were exam-
ined by light microscopy.
India ink lung staining
At 4 weeks after tail vein injection, mice were sacrificed
and India ink (15%) was injected into their lungs
through the trachea. The lungs were fixed in Fekete’s
solution (100 mL of 70% alcohol, 10 mL formalin, and 5
mL glacial acetic acid) at room temperature. After
destaining, the lungs were photographed.
Statistical analysis
Every experiment was repeated at least three times and
statistical analysis was performed by one way ANOVA
using JMP5.0 Software (SAS Inc, Cary, NC). Fisher’s
LSD post-hoc test was applied to assess differences of
expression levels between each cell type. A value of p ≤
0.05 was considered statistically significant.
Results
In 4T1 cells integrin a5 subunit levels are low and
integrin a6 subunit levels are high
Since integrins are thought to have a major role in regu-
lating tumor growth and metastasis, we examined the
expression levels of integrins in highly invasive (4T1 and
4T07) and noninvasive (67NR) mouse breast cancer
cells. Using FACS analysis, we measured the expression
levels of 7 integrins, a4, a5, a6, b1, b2, a2b1, and avb6.
Our results showed that integrin a5 subunit levels were
lowest in 4T1, moderate in 4T07, and highest in 67NR
cells (Figure 1A). In contrast, integrin a6 subunit
expression was highest in 4T1, moderate in 4T07, and
lowest in 67NR cells (Additional File 1, Figure 1B).
Expression of the other integrins (a4, b1, b2, a2b1,
avb6) was very low in these cell lines (Additional File
1). RT-PCR and Western blot analysis validated the dif-
ferent levels of expression of integrin subunits a5a n d
a6 in 4T1, 4T07, and 67NR cells (Figure 2A, B). These
findings suggest that the a5a n da6 integrins may have
a critical role in tumor growth and metastasis.
To investigate the potential role of integrin subunits a5
and a6 on tumor cell invasion and metastasis of 4T1
cells, we stably transfected these cells with full-length
cDNA for mouse integrin a5 subunit and pRNAT-H1.1/
neo, which contained the shRNA-control or shRNA-1
for mouse integrin a6 subunit. 4T1-GFP was also used
as a control. Mixtures of G418 resistant clones from
these stable transfections were tested for the integration
of integrin a5 subunit overexpression and integrin a6
subunit knockdown by RT-PCR and Western blot ana-
lyses. Our findings demonstrate that the expression
levels of integrin a5 in the transfected cells increased as
compared with levels in controls (Figure 2C). For integ-
rin a6 subunit knockdown stable cells, both RT-PCR
and Western blot analyses demonstrated that shRNA-1
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Figure 1 Flow cytometric analysis of integrins. Analysis was performed for integrin a5( A)a n da6( B) on mouse breast cancer cell lines 4T1
(control), as well as 4T07 and 67NR. The fluorescence signals of unstained cells (primary antibody omitted) for each cell type were presented as
blue peaks and served as the basal level of cell-surface expression. The fluorescence signal for integrin a5 and a6 subunits were presented as
open peaks. Histograms presented the positive cell percentage of each cell type and the differences are statistically significant (P < 0.01). All
experiments were repeated three times.
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over, the expression level of a6 was significantly
decreased (Figure 2D). In contrast, shRNA-control
(alpha6-2) did not affect integrin a6 subunit expression
at either the RNA or protein level (Figure 2D).
Integrin a5 subunit overexpression and a6 subunit
knockdown inhibit 4T1 cell proliferation
Since cell proliferation is an important regulator of
tumor growth, we examined the potential roles of integ-
rin a5a n da6 genes on cell growth. We used 4T1 con-
trol, GFP-4T1, 4T1-a5, and 4T1-a6-shRNA1 cells and
measured cell growth by the MTT method. The prolif-
eration curves of 4T1 control and 4T1-GFP cells were
quite similar at all time points (Figure 3A). The in vitro
proliferation ability of 4T1 cells was significantly inhib-
ited at 48 hr by overexpression of integrin a5 subunit
(0.30 ± 0.08 versus 0.61 ± 0.07 for 4T1-a5 and 4T1-
GFP, respectively; p < 0.01) and 96 hr (0.88 ± 0.14 ver-
sus 1.47 ± 0.09 for 4T1-a5 and 4T1-GFP, respectively; p
< 0.01). Similarly, integrin a6 subunit knockdown had a
significant inhibitory effect on 4T1 cell proliferation at
48 hr (0.41 ± 0.04 versus 0.61 ± 0.07 for 4T1-a6-
shRNA1 and 4T1-GFP, respectively; p < 0.01) and 96
hours (1.01 ± 0.21 versus 1.47 ± 0.09, p < 0.01) (Figure
3A). The effect of a6 knockdown on cell proliferation
was not quite as robust as that of a5 overexpression.
However, alpha6 knockdown did significantly inhibit cell
proliferation (Figure 3A). These results suggest that
overexpression of a5 and knockdown of a6 reduce cell
growth in vitro.
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Figure 2 Validation of expression of integrins by RT-PCR and
Western blot analysis. Expression levels of integrin a5( A) and a6
subunits (B) were validated by RT-PCR and Western blotting. RT-PCR
was done using the integrin a5- and a6-specific primers. GAPDH
was used as the loading control. Cell lysates were prepared and
Western blotted with anti-integrin a5 or anti-integrin a6 antibody.
Vinculin blotting was used for equal loading. Integrin a5
overexpression (C) and a6 knockdown (D) were also validated by
RT-PCR and Western blot. Stable cell lines overexpressing integrin
a5 and knockdown a6 were established. RNA and protein lysates
were used to demonstrate the expression of the plasmids.
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Figure 3 Modulation of integrin expression inhibits cell
proliferation, migration and invasion. A. Cell proliferation of 4T1
cells. 4T1 control, 4T1-GFP, 4T1-a5, and 4T1-a6-shRNA1 cells were
seeded and MTT assays done at 24-hr intervals. MTT data were
plotted based on the average absorbance value and standard
deviation. The Y axis presents the absorbance at 572 nm; the X axis
represents incubation time. Black curve: 4T1 control; red curve: 4T1-
GFP cells; green curve: 4T1-a5 cells; blue curve: 4T1-a6-shRNA1 cells.
** p < 0.01 (as compared to GFP-4T1). We found that the in-vitro
proliferation ability of 4T1 cells is inhibited by overexpression of
integrin a5 and knockdown of integrin a6. B. A transwell migration
assay was done for 4T1 (control), GFP-4T1, 4T1-a5, and 4T1-a6-
shRNA1 cells. The number of cells that migrated to the lower
surface of the filter membrane was counted in 5 random fields
under a light microscope (×200). The ability of 4T1 cells to migrate
was significantly diminished by overexpression of integrin a5( p<
0.01) and knockdown of 4T1-a6-shRNA1 (p < 0.05). C.
Representatives of cell migration figures for each cell type. D. A cell
invasion assay was done for 4T1, 4T1-GFP, 4T1-a5, and 4T1-a6-
shRNA1 cells. 0.1% crystal violet solution was used to stain the
lower chamber of transwell. The number of cells that invaded the
Matrigel and penetrated the transwell pore to the lower surface was
counted in 5 random fields under a light microscope (×200).
Overexpression of integrin a5 and knockdown of a6 inhibited the
ability of 4T1 cells to invade (p < 0.01).
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knockdown inhibit 4T1 cell migration and cell invasion
Cell migration, a central process in the development and
maintenance of multicellular organisms, has been shown
to be involved in tumor formation and metastasis.
Therefore, using the classic transwell in vitro cell migra-
tion assays, we investigated whether integrin a5s u b u n i t
overexpression and integrin a6 subunit knockdown
affect the migration ability of 4T1 cells. As shown in
Figure 3B and 3C, the in vitro migration ability of 4T1-
a5 cells was significantly decreased as compared to that
of 4T1 control and 4T1-GFP cells. The numbers of
migrated cells were 17.67 ± 1.0, 49 ± 4.95 and 49 ±
1.86, respectively, for 4T1-a5, 4T1 control, and 4T1-
GFP cells (p < 0.01). Similarly, the number of 4T1-a6-
shRNA1 cells (36.17 ± 8.25) that migrated through the
transwell membrane was significantly lower than the
number of 4T1 control cells (49 ± 4.95) and 4T1-GFP
cells (49 ± 1.86) that did so (p < 0.05) (Figure 3B, C).
Furthermore, to define the functional changes of the
integrins, migration of 4T1 and 67NR cells was carried
out using either alpha5 integrin or alpha6 integrin func-
tional antibodies. As shown in additional file 2, migra-
tion of 67NR cells (that have high levels of a5 integrin)
was enhanced in the presence of a5 integrin blocking
antibody, further suggesting a5 integrin suppresses cell
migration. Also migration of 4T1 cells (that have high
levels of a6 integrin) was decreased in the presence of
a6 integrin blocking antibody (Additional File 2).
Cell invasion is an important regulator of tumor
growth and metastasis. To explore the functional effect
of integrin a5a n da6 genes on the invasiveness of 4T1
cells, we did in vitro Matrigel invasion assays on these
cell lines. Our results showed that the numbers of 4T1-
a5 and 4T1-a6-shRNA1 cells that passed through the
Matrigel and transwell membrane were significantly
lower than the number of cells in the 4T1-GFP control
group that did so, indicating that these integrins have
important role in cell invasion (Figure 3D).
Integrin a5 overexpression and a6 knockdown inhibit
metastasis
Since a5a n da6 have dramatic effects on tumor cell
migration and invasion, we hypothesized that these
integrins may also have an effect on breast cancer
metastasis. Thus we examined the effect of integrins on
metastasis in vivo. 4T1 cells overexpressing a5i n t e g r i n
subunit and a6 subunit underexpressing cells (with their
controls) were injected into the tail veins of nude mice.
Lung metastasis was examined four weeks later. Mice
injected with 4T1-a5 and 4T1-a6-shRNA1 cells showed
a dramatic decrease in pulmonary metastases, while
mice injected with 4T1 control and 4T1-GFP cells pro-
duced many metastatic nodules (Figure 4Ai, Bi, Ci, Di).
When we dissected the lungs and filled them with 15%
India ink, the metastatic tumors, after fixation in
Fekete’s solution, appeared as white nodules on the
black lung surface (Figure 4Aii, Bii, Cii, Dii). H&E stain-
ing of the lungs of these mice showed that the presence
of a5 and the reduction of a6 reduced lung metastases,
while their controls had large numbers of metastases
(Figure 4Aiii, Biii, Ciii, Diii). In contrast, the lungs of
mice injected with vector control cells were heavily infil-
trated with metastases. To our surprise 4T1-a5a n d
4T1-a6-shRNA1 cells did not have any effect on breast
tumor growth, when we injected them into mammary
fat pads (data not shown)., and the reasons for these
results are currently unknown. These data suggest that
the a5 integrin subunit may function as a metastasis
suppressor while a6 subunit may function as a metasta-
sis promoter.
Our in vitro studies suggest that integrins have an
effect on cell proliferation. To investigate this in vivo,
we did immunohistochemical analysis for Ki67, a marker
for proliferation. In the lungs of mice, altered integrin-
expressing tumors had significantly less Ki67 staining
than they did in GFP-expressing controls (Figure 4Aiv,
Biv, Civ, Div and quantitative data shown in Additional
File 3), supporting a role for integrin a5a n da6 subu-
nits in regulating tumor growth, in part through effects
on cell proliferation.
As described, overexpression of integrin a5a n d
knockdown of integrin a6 subunits inhibited 4T1 cell
proliferation ability. Since cell growth is regulated by
positive and negative regulators of the cell cycle, we
analyzed the effects of alpha5 integrin and alpha6 integ-
rin subunits on cell-cycle progression and its associated
proteins. To understand the mechanism whereby integ-
rin a5 and integrin a6 subunits affect cell proliferation,
we examined the cell cycle using 4T1 control, 4T1-GFP,
4T1-a5a n d4 T 1 - a6-shRNA1 cells. To determine the
effects on cell-cycle progression, we did flow cytometry
using propidium iodide. The alpha5 overexpression and
knockdown of alpha6 integrin demonstrated a G1/S
arrest, which resulted in a decrease in the S-phase popu-
lation (Figure 5A). This suggested that overexpression of
a5 integrin and knockdown of a6 integrin do not allow
cells to pass the S phase. As a result, these cells might
have inhibited growth.
Gene expression level of cell-cycle-related genes
To examine the mechanism by which a5a n da6i n t e g -
rin subunits regulate cell-cycle progression, we did
microarray analysis using a cell-cycle gene array con-
taining cell-cycle genes (SA Biosciences). Cell-cycle
microarray profiling was done using RNA prepared
from 4T1-GFP, 4T1-a5, and 4T1-a6.shRNA1 cells to
examine changes in cell-cycle-related genes. We found
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Page 6 of 11that the expression of chk-1 and E2F-1 was elevated and
cyclin E, CDK2 and cdc25A were decreased in 4T1-a5
and 4T1-a6-shRNA1 cells compared to 4T1-GFP cells
(Additional File 4). Later, we validated these data by
RT-PCR (Figure 5B and data not shown). Although DST
gene levels are significantly high in 4T1-a5 and 4T1-a6-
s h R N A 1c e l l s ,w ew e r eu n a b l et ov a l i d a t et h ed a t ab y
RT-PCR, and thus it is not further studied. The results
suggested that overexpression of alpha5 and knockdown
of alpha6 reduces cell growth by enhancing the expres-
sion of chk1 and E2F1 and down regulating the expres-
sion of cyclin E and CDK2.
Downregulation of cyclin E/CDK2 complexes
We analyzed the effects of integrin a5 subunit overexpres-
sion and a6 subunit knockdown on cell-cycle associated
proteins, as shown in Figure 6A, that cells overexpressing
a5 integrin and a6 knock-down cells decreased the
expression of cyclin E, but not cyclin-D. Consistent with
this finding, levels of CDK2, a binding partner of cyclin E,
also decreased in the cells. However, no change in the
level of CDK4 was observed. These data corroborated the
cell cycle array data and suggest that the integrins regulate
cell growth through their effects on cell-cycle regulatory
proteins. Because it is known that cdc25a regulates CDK2/
Ai Bi
Ci Di
Aii Bii
Cii Dii
Aiii
Ciii
Aiv Biv
Civ
Biii
Div Diii
4T1  4T1-GFP
4T1-α5 cDNA 4T1-α6-1 shRNA 
H&E H&E
H&E H&E Ki67 Ki67
Ki67 Ki67
India Ink
India Ink
India Ink
India Ink
4% PFA  4% PFA 
4% PFA  4% PFA 
Figure 4 Overexpression of integrin a5 subunit and knock down of a6 subunit decreased pulmonary metastasis of 4T1 cells.1×1 0
6
4T1 control, GFP-4T1, 4T1-a5, and 4T1-a6-shRNA1 cells were resuspended in 0.1 ml PBS and used to inject nude mice in their lateral tail veins.
After four weeks, the mice were euthanized and their lungs were removed, fixed in 4% paraformaldehyde, and analyzed for metastasis.
Representative examples of the lung tissues from each group are shown. A: Lungs from 4T1 control-cell-injected mice; B: Lungs from 4T1-GFP
cells injected mice., C: Lungs from 4T1-a5 injected mice., D: Lungs from mice injected with 4T1 a6-shRNA1; Ai, Bi, Ci, and Di: Lung images taken
right after formaldehyde fixation. Aii, Bii, Cii, and Dii : Lungs stained with India ink:. Aiii, Biii, Ciii, Diii: H&E stained lung sections. Aiv, Biv, Civ, and
Div: Ki67 stained lung sections. Scale bar: 100 microns.
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Page 7 of 11cyclin E, we examined whether modulation of integrin a5
and a6 subunits have any effect on cdc25a. We found that
both overexpression of a5 and knockdown of a6 downre-
gulated the expression of cdc25a (Figure 6A), suggesting
that inhibition of cdc25a may be a reason for downregula-
tion of cdk2 and cyclin E.
Upregulation of Chk1 and P27 expression
We also examined the expression levels of cyclin-depen-
dent kinase inhibitors in theG 1 / Sp h a s e ,f i n d i n gt h a t
the expression level of p27 was significantly increased
(Figure 6A). Since our cell-cycle array data indicated
that a5 overexpression and a6 integrin subunit-reduced
expression caused upregulation of chk1 at the RNA
level, we examined the expression of chk1 at the protein
level. Consistent with the RNA data, protein expression
levels were also increased, suggesting that chk1 upregu-
lation could be another mechanism by which these
integrins regulate metastasis. Rb phosphorylation is
pivotal in controlling cell proliferation by upregulating
the G1/S transition of the cell cycle. During the contin-
uous proliferation of cells, pRb is phosphorylated by the
activity of G1 phase CDKs such as CDK4 and CDK2,
thereby liberating factors that control the S-phase
entrance. Consistent with our cyclin E/CDK2 data, these
integrin modulations inhibited Rb phosphorylation.
Also, to our surprise, we found increased E2F1 levels in
these integrin-modulated cells (Figure 6A), which is
consistent with the cell-cycle array data. These data sug-
gest a5a n da6 integrin subunits regulate metastasis
through their effects on cell cycle regulated proteins.
Discussion
In this investigation of the expression levels of 8 integ-
rins on the surfaces of cells from mouse breast cancer
cell lines 4T1, 4T07, and 67NR, only a5 and a6 integrin
subunits showed changes in expression levels in differ-
ent invasive cell types. The a5 integrin subunit had the
lowest expression in highly metastatic 4T1 cells, and lit-
tle more in 4T07; its highest expression was in 67NR. In
contrast, integrin a6h a dt h eo p p o s i t ee x p r e s s i o np a t -
tern, as compared to a5 subunit. Our results also
showed that overexpression of integrin a5 subunit sig-
nificantly inhibited 4T1 cell proliferation, cell migration,
and cell invasion in vitro. Our cell-cycle data indicate
that 4T1-a5 cells were arrested at G1/S phase and that
a lesser number of cells entered into S phase. Also, our
in vivo study showed that pulmonary metastasis of 4T1-
a5 cells was greatly decreased compared to metastasis
of 4T1 and 4T1-GFP cells. Based on these findings, we
postulate that integrin a5 subunit functions as an inhi-
bitor of metastasis in mouse breast cancer cell line 4T1.
Consistent with our data, lower expression levels of
integrin a5 were observed in several cancerous tissues,
including hepatocellular carcinoma [7,13], prostate car-
cinoma [14], and gastric, colorectal, and breast carci-
noma [7]. Also previous reports indicated that
overexpression of a5b1 inhibits proliferation of human
HT29 colon carcinoma cells in vitro and reduces the
formation of lung colonies and cutaneous metastases in
vivo [15,16]. Similarly, overexpression of integrin a5i n
human hepatocellular carcinoma cells reduces cell pro-
liferation, decreases cell colony formation, and changes
the cell-cycle pattern [17]. Elevated levels of a5b1
Figure 5 Modulation of integrins regulates cell cycle
progression. A: 4T1, GFP-4T1, 4T1-a5, and 4T1-a6-shRNA1 cells
were synchronized and stained with propidium iodide for cell-cycle
analysis. Cells were arrested at G1/S stage for 4T1-a5 and 4T1-a6-
shRNA1 (37 and 42) compared to controls (26 and 28), and have
shorter S phase for 4T1a5 and 4T1 a6 shRNA(52, 49) compared to
controls (65, 67). No significant changes in G2 phase were noted
(4T1 a5:10, 4T1 a6-shRNA1;8, 4T1 control: 8, and 4T1 GFP: 7). B. RT-
PCR data. RNA was isolated from all the four cell lines and RT-PCR
was performed for E2F1, chk1, Cyclin E and CDK2. GAPDH control
was used as a control.
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Page 8 of 11suppress the transformed phenotype of Chinese hamster
ovary cells [18] and reduce tumorigenesis in a mouse
model [19]. Niu et al. found that the proliferation of
K562 cells could be inhibited by IFNa-2b by restoring
the function of integrin a5a n db1 and enhancing their
ability to bind to FN, which in turn upregulates FAK
gene expression [20].
There are, however, some contradicting reports show-
ing that integrin a5 may function as an oncogene and is
associated with malignant tumor progression. Survival
analysis of non small-cell lung cancer patients with
integrin a5-overexpressing tumors had a worse overall
survival rate than did patients whose tumors had normal
integrin a5 expression [21]. Further, the integrin a5
molecule has been reported to promote melanoma
metastasis in vitro and in vivo [22]. Integrin a5 up-regu-
lation was identified as the molecular mechanism by
which E-cadherin loss promotes tumor progression [23]
and ERBB2-mediated transcriptional up-regulation of
the a5b1 promotes tumor cell survival under adverse
conditions [24]. Thus, integrin a5 has different func-
tions in different carcinoma cell lines. The reasons for
these diverse functions of integrin a5 in cancer progres-
sion and metastasis are still unclear; however, it has
been suggested that a5b1 may affect different signaling
cascades and might function differently depending on its
adhesion or lack of adhesion to fibronectin [21].
Our results show that knockdown of integrin a6s u b -
unit expression inhibited 4T1 cell proliferation, migra-
tion, and invasion. Consistent with these findings, the
enhancement of cell migration and invasion by integrin
a6( a6b1a n da6b4) has been shown in pancreatic car-
cinoma cells [11], and breast cancer [25]. Unlike integrin
a5, which functions as either an oncogene or a tumor
suppressor, a6i n t e g r i n( a6b1a n da6b4) has been
implicated only in promoting tumor progression
[26-29]. Recent evidence has demonstrated that integrin
a6 is necessary for tumorigenicity of a stem-cell-like
subpopulation within the MCF7 breast cancer cell line
[30]. Integrin a6 can form heterodimers with either b1
or b4. Both heterodimers (a6b1 and a6b4) are receptors
for laminin, a component of basement membrane [31].
Higher expression level of a6( a6b1 and a6b4) was also
observed in malignant gastrointestinal stromal tumors
[32] and human hepatocellular carcinoma cells [17].
These results suggest that alpha 6 integrin is important
in tumorigenesis.
Our results indicate that overexpression of a5 integrin
and reduction of a6 integrin subunits prevents cells
from passing G1/S phase transition, so that cells in S
Figure 6 Modulation of integrin expression regulates expression of cell-cycle modulators known to induce G1 arrest. A. Western blots
show the expression of cyclin E, cdk2, p27, pRb, chk1, cdc25A, and E2F1 in 4T1 control, 4T1 GFP, 4T1 a5 overexpressing, and 4T1 a6 knocked-
down cells. B: Our current model showing the mechanism of integrin modulation in breast cancer progression. This model shows
overexpression of integrin a5 or reduced expression of a6 causes upregulation of chk1. This, in turn, causes downregulation of cdk2/cyclin E to
reduce phosphorylation of retinoblastoma protein. This integrin modulation enhances the expression of E2F, which may stimulate chk1
expression, which regulates cdc25a function, in a feedback loop mechanism.
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Page 9 of 11phase accumulate. Since our work indicated growth
arrest in the G1 phase of the cell cycle and based on
PCR array data, we investigated whether cyclin E is
affected by integrin modulation. Cyclin E/CDK2 com-
plex is a major regulator of G1/S phase transition. The
major function of cyclin E is to promote progression
through the G1/S phase of the cell cycle by associating
with CDK2 to phosphorylate and inactivate retinoblas-
toma protein and release E2F transcription factors [33].
The activities of the CDKs are regulated by several
mechanisms, including binding of cyclins, phosphoryla-
tion, and dephosphorylation, as well as binding to CDK
inhibitors (CKIs). Overexpression of a5 integrin and
downregulation of a6 regulate the expression of cyclin E
and CDK2, but not that of cyclin D. P27Kip1, a member
of the cip/Kip family of CKIs, alters the activities of
cyclin D1 in quiescent cells, leading to failure of the G1/
S transition and cell-cycle arrest. Our results indicate
that the modulation of the integrins enhances p27
expression. Consistent with this, phosphorylation of pRb
is decreased, suggesting that the integrin modulation
regulates metastasis affecting Rb phosphorylation.
Furthermore, the changes in integrin expression cause
upregulation of chk1 and downregulation of Cdc25A
expression. Chk1 inhibits Cdc25A expression, whereas
Cdc25A phosphatase dephosphorylates and activates
CDK2/cyclin E complex during the G1-S transition in
proliferating cells[34]. Cdc25A is negatively regulated by
phosphorylation of chk 1, which is involved in an S-
phase check point pathway that responds to genotoxic
stress evoked by DNA damaging agents or irradiation
[33]. It is currently unknown how chk1 is induced upon
overexpression of a5 or reduction of a6 integrin. In
addition, although the mechanism responsible for these
changes is not known, our results indicate that E2F1
expression is upregulated as a result of integrin expres-
sion changes. Chk1 has been shown to phosphorylate
Cdc25A, downregulating its phosphatase activity
through distinct mechanisms [34]. For instance, Worms
and colleagues reported that chk1 kinase negatively reg-
ulates mitotic function of Cdc25A phosphatase through
14-3-3 binding[35].
Based on our results, we propose the following model.
Integrin a5 subunit overexpression or reduction of a6
subunit integrin upregulates chk1, which leads to down-
regulation of cdc25A; this in turn reduces the activity of
cyclin E/CDK2. The reduction of activation causes
decreased pRb phosphorylation and, as a consequence,
cell-cycle growth is inhibited. Simultaneously, p27 is
upregulated, which also can downregulate the expres-
s i o nC D K 2 .F u r t h e r m o r e ,E 2 Fi su p r e g u l a t e d ,w h i c h
may cause enhanced expression of chk1, a regulator of
E2F1. This may upregulate chk1 to downregulate
cdc25A in a feedback loop mechanism.
Additional material
Additional file 1: Expression level of integrins of 4T1, 4T07 and
67NR cells by flow cytometry. Percentage expression values of
integrins are shown.
Additional file 2: Effect of blocking antibodies on cell migration.A
transwell migration was done for 67NR cells with IgG control or with
alpha5 integrin blocking antibody on fibronectin and 4T1 cells with IgG
control or with alpha6 integrin blocking antibody on laminin. Blocking
alpha5 integrin enhanced cell migration while blocking alpha6 antibody
decreased cell migration and both the effects are statistically significant.
Additional file 3: Quantitation of Ki67 cells in lung sections. Lung
sections stained with Ki67 antibody (described in Aiv, Biv, Civ, and div)
were quantitated. The differences between 4T1GFP and 4T1a5, and
4T1GFP and 4T1a6 shRNA1 were statistically significant.
Additional file 4: Cell cycle microarray data. RNA prepared from 4T1
control cells, 4T1 GFP, 4T1 a5, 4T1 a6-1 were used to screen the
expression profile of various cell cycle related genes using cell cycle
specific arrays quantitative RT PCR assay. Based on average delta CT
values, fold change (regulation) was generated and the values were
shown in the table. The candidate genes of interest were depicted in
bold.
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